JP2021151979A - 再生医療薬 - Google Patents
再生医療薬 Download PDFInfo
- Publication number
- JP2021151979A JP2021151979A JP2020070634A JP2020070634A JP2021151979A JP 2021151979 A JP2021151979 A JP 2021151979A JP 2020070634 A JP2020070634 A JP 2020070634A JP 2020070634 A JP2020070634 A JP 2020070634A JP 2021151979 A JP2021151979 A JP 2021151979A
- Authority
- JP
- Japan
- Prior art keywords
- enzyme
- tissue
- regenerative medicine
- organ
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
再生医療とは、幹細胞等を用いて、臓器や組織の欠損や機能障害・不全に対し、それらの臓器や組織を再生し、失われた人体機能の回復を目指す医療である。本発明は、欠損した臓器や組織以外の正常に機能している臓器や組織細胞の細胞分裂を復活させることにより、臓器や組織を再生する。
細胞の分裂回数は有限であり、ヘイフリック限界と呼ばれている。細胞の分裂回数は染色体の端にあるテロメアで決まり、細胞分裂を繰り返すたびにテロメアが短くなり、ある程度短くなるとヘイフリック限界に達する。
酵素テロメラーゼはテロメアを伸長させる酵素である。酵素テロメラーゼを細胞に投与することによりテロメアを伸長させ、再び細胞分裂を復活させる状態に回復させる。
酵素ASB7は細胞分裂を正常に行う酵素である。酵素ASB7を酵素テロメラーゼと同時に細胞に投与することにより、再び細胞分裂を復活させる。
酵素テロメラーゼと酵素ASB7を使用する再生医療薬を、手術により再生医療の対象の欠損した臓器や組織以外の正常に機能している臓器や組織の細胞に直接投与する。
再生医療薬の投与の量は臓器や組織の再生する割合に応じて決める。
Claims (1)
- 酵素テロメラーゼと酵素ASB7の両方をリポソーム医薬品として投与する再生医療薬。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020070634A JP2021151979A (ja) | 2020-03-24 | 2020-03-24 | 再生医療薬 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020070634A JP2021151979A (ja) | 2020-03-24 | 2020-03-24 | 再生医療薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2021151979A true JP2021151979A (ja) | 2021-09-30 |
Family
ID=77887206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020070634A Pending JP2021151979A (ja) | 2020-03-24 | 2020-03-24 | 再生医療薬 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2021151979A (ja) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001510985A (ja) * | 1996-10-01 | 2001-08-07 | ジェロン コーポレイション | ヒトテロメラーゼ触媒性サブユニット |
-
2020
- 2020-03-24 JP JP2020070634A patent/JP2021151979A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001510985A (ja) * | 1996-10-01 | 2001-08-07 | ジェロン コーポレイション | ヒトテロメラーゼ触媒性サブユニット |
Non-Patent Citations (2)
Title |
---|
J. CELL BIOL. (2016) VOL.215, NO.1, P.95-106, JPN6020026441, ISSN: 0004377725 * |
細胞分裂に必要な酵素ASB7の発見,PRESS RELEASE,名古屋大学,2016-10-05,[検索日2020-07-16], インター, JPN6020026442, ISSN: 0004377726 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2020168015A5 (ja) | ||
Roberson et al. | Angiography and embolization of the internal maxillary artery for posterior epistaxis | |
TWI488641B (zh) | 椎間盤突出治療劑 | |
JP2021151979A (ja) | 再生医療薬 | |
Maciąg et al. | Long-term temporary pacing with an active fixation lead | |
Spinler et al. | Clinical presentation and analysis of risk factors for infectious complications of implantable cardioverter-defibrillator implantations at a university medical center | |
Terzi et al. | Comparison of phenol and trichloroacetic acid chemical matricectomies in the treatment of unguıs inkarinatus | |
Nagaiah et al. | Biofilms associated with biomedical implants and combating therapies | |
Szotkowski et al. | Acute promyelocytic leukemia successfully treated also in elderly patients with significant comorbidities: a 20-year single-center experience | |
Kim et al. | Ticagrelor does not affect left ventricular remodeling following acute myocardial ischemia | |
RU2582228C1 (ru) | Способ профилактики и лечения послеоперационного воспаления полости рта | |
Aoun et al. | Antibiotic therapy and bacterial odontogenic infections: An overview | |
JP2022151421A (ja) | 骨粗しょう症治療薬 | |
RU2725244C1 (ru) | Способ лечения пародонтита | |
Perdigoto et al. | VISCOSUPPLEMENTATION OF THE UPPER AND LOWER COMPARTMENTS OF TEMPORO-MANDIBULAR ARTICULATION (TMJ)–OSTEOARTHRITIS AND OSTEOARTHROSIS CONTROL | |
Doğan et al. | Red Eye and Red Face Following Defibrilation. | |
Thomson | The living dead | |
Kraan | Bilateral resection therapy in pulmonary tuberculosis | |
Biradar et al. | Intraarticular corticosteroid injection in adhesive capsulitis: are two doses better than a single dose? a randomized prospective study. | |
Kaplan et al. | Rhinocerebral mucormycosis. | |
Shishido et al. | Optimal Management of Severe Mpox in Patients with Uncontrolled HIV | |
JP2022151422A (ja) | 骨折治療薬 | |
Škrgatić et al. | The effect of ulipristal acetat treatment on fibroid volume and quality of life among women of reproductive age | |
Chakravarthy et al. | Knowledge and Attitude Levels on Regenerative Endodontic Procedures among the Dental Residents in and around Puducherry | |
Posligua et al. | 18121 Undifferentiated pleomorphic dermal sarcoma with unusual keratoacanthoma-like clinical presentation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20200409 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20200617 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200804 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20201110 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20201120 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210203 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20210512 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20210727 |
|
C30A | Notification sent |
Free format text: JAPANESE INTERMEDIATE CODE: C3012 Effective date: 20211220 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20220502 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20220830 |
|
C13 | Notice of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: C13 Effective date: 20230124 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20230421 |